Smith–Lemli–Opitz syndrome disease incidence has been studied, primarily in Europe and Canada. Diagnoses have been confirmed by molecular and biochemical methods. Most figures range from 1/60 00011, 12 to 1/20 000.
Get more content like this and the inside gist on all the fun things that happen at Healthsoothe straight to your inbox when you Subscribe to the Healthsoothe newsletter. Do it now!